A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Adding the drug enzalutamide to standard hormone therapy reduced the risk of premature death by more than 40% in patients ...

Kids with a rare bone cancer called Ewing sarcoma might live longer if prescribed pazopanib, a drug that blocks blood supply ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...

The United States Prostate Cancer Biomarkers Market is projected to grow from $1.48 billion in 2024 to $3.54 billion by 2033, ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

Men with advanced prostate cancer may live longer if they take statins alongside apalutamide and standard hormone therapy, a ...